Demographic and Clinical Factors Associated with Health-Related Quality-of-Life Profiles among Prostate Cancer Survivors

Arnold L. Potosky*, Jaeil Ahn, Yi Xia, Li Lin, Ronald C. Chen, Kristi D. Graves, Wei Pan, Jane M. Fall-Dickson, Theresa H.M. Keegan, Lisa E. Paddock, Xiao Cheng Wu, Anshu Shrestha, Bryce B. Reeve

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

PURPOSEOur purpose was to describe the prevalence and predictors of symptom and function clusters related to physical, emotional, and social components of general health-related quality of life (HRQOL) in a population-based sample of prostate cancer (PCa) survivors.METHODSParticipants (N = 1,162) completed a baseline survey at a median of 9 months after diagnosis to ascertain the co-occurrence of eight symptom and functional domains that are common across all cancers and not treatment-specific. We used latent profile analysis (LPA) to identify subgroup profiles of survivors with low, moderate, or high HRQOL levels. Multinomial logistic regression models were used to identify clinical and sociodemographic factors associated with survivors' membership in the low versus moderate or high HRQOL profile.RESULTSThe LPA identified 16% of survivors who were categorized in the low HRQOL profile at baseline, indicative of the highest symptom burden and lowest functioning. Factors related to survivors' membership in the low versus higher HRQOL profile groups included less than age 65 years at diagnosis, identifying as non-Hispanic Black race, not working, being a former versus never smoker, systemic therapy, less companionship, more comorbidities, lower health care financial well-being, or less spirituality. Several factors remained associated with remaining in the low versus higher HRQOL profiles on the follow-up survey (n = 699), including younger age, Black race, comorbidity, and lower financial and spiritual well-being.CONCLUSIONAbout one of six PCa survivors experienced elevated physical and psychosocial symptoms that were independent of local curative therapy, but with younger age, race, comorbidity, and lower financial and spiritual well-being as stable risk factors for poor HRQOL over time.

Original languageEnglish
Pages (from-to)921-931
Number of pages11
JournalJCO Oncology Practice
Volume20
Issue number7
DOIs
StatePublished - 1 Jul 2024

Cite this